Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes

Catherine C. Robertson(University of Virginia), Stephen S. Rich(Virginia Department of Health), Robert P. Kimberly(Regeneron (United States)), Hanzhi Yang(University of Virginia), David B. Dunger(Addenbrooke's Hospital), Jane H. Buckner(Benaroya Research Institute), Carla J. Greenbaum(Society of Interventional Radiology), Flemming Pociot, David Flores Santa Cruz(Centre for Human Genetics), Amy S. Shah(Cincinnati Children's Hospital Medical Center), Antony J. Cutler(University of Cambridge), Jamie Inshaw(Centre for Human Genetics), Marian Rewers(University of Colorado Denver), Jasmin Divers(Wake Forest University), Mark A. Atkinson(University of Florida), Linda S. Wicker(Juvenile Diabetes Research Foundation), Santica M. Marcovina(Medpace (United States)), Jean M. Lawrence(National Institute of Diabetes and Digestive and Kidney Diseases), Daniel J. M. Crouch(Centre for Human Genetics), Patrick Concannon(University of Florida), Emily Farber(University of Virginia), Peter K. Gregersen(Northwell Health), Panos Deloukas(Queen Mary University of London), Dana Dabelea(Colorado School of Public Health), Jorge R. Oksenberg(University of California, San Francisco), Suna Önengüt-Gümüşcü(University of Virginia), S. Louis Bridges(Hospital for Special Surgery), Wei‐Min Chen(University of Virginia), John A. Todd(University of Oxford), Jeffrey C. Edberg(University of Alabama at Birmingham Hospital), Andrea K. Steck(University of Colorado Anschutz Medical Campus)
Nature Genetics
June 14, 2021
Cited by 302


Related Papers